Literature DB >> 24292556

Splicing factor SRSF3 represses the translation of programmed cell death 4 mRNA by associating with the 5'-UTR region.

J Kim3, R Y Park2, J-K Chen3, J Kim3, S Jeong1, T Ohn2.   

Abstract

Serine/arginine-rich splicing factor 3 (SRSF3), a member of the serine/arginine (SR)-rich family of proteins, regulates both alternative splicing of pre-mRNA and export of mature mRNA from the nucleus. Although its role in nuclear mRNA processing is well understood, the mechanism by which it alters the fate of cytoplasmic mRNA molecules remains elusive. Here, we provide evidence that SRSF3 not only regulates the alternative splicing pattern of programmed cell death 4 (PDCD4) mRNA, but also modulates its translational efficiency in the cytoplasm by lowering translation levels. We observed a marked increase in PDCD4 mRNA in translating polysome fractions upon silencing of SRSF3, and, conversely, ectopic overexpression of SRSF3 shifted PDCD4 mRNA into non-translating ribosomal fractions. In live cells, SRSF3 colocalized with PDCD4 mRNA in P-bodies (PBs), where translationally silenced mRNAs are deposited, and this localization was abrogated upon SRSF3 silencing. Furthermore, using two different reporter systems, we showed that SRSF3 interacts directly with PDCD4 mRNA and mediates translational repression by binding to the 5'-untranslated region (5'-UTR). In summary, our data suggest that the oncogenic potential of SRSF3 might be realized, in part, through the translational repression of PDCD4 mRNA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24292556      PMCID: PMC3921596          DOI: 10.1038/cdd.2013.171

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  39 in total

1.  Involvement of SR proteins in mRNA surveillance.

Authors:  Zuo Zhang; Adrian R Krainer
Journal:  Mol Cell       Date:  2004-11-19       Impact factor: 17.970

2.  Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.

Authors:  Y Tang; I Horikawa; M Ajiro; A I Robles; K Fujita; A M Mondal; J K Stauffer; Z-M Zheng; C C Harris
Journal:  Oncogene       Date:  2012-07-09       Impact factor: 9.867

Review 3.  SRprises along a messenger's journey.

Authors:  Yingqun Huang; Joan A Steitz
Journal:  Mol Cell       Date:  2005-03-04       Impact factor: 17.970

4.  Cloning of the TIS gene suppressed by topoisomerase inhibitors.

Authors:  Y Onishi; S Hashimoto; H Kizaki
Journal:  Gene       Date:  1998-07-30       Impact factor: 3.688

5.  Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death.

Authors:  K Shibahara; M Asano; Y Ishida; T Aoki; T Koike; T Honjo
Journal:  Gene       Date:  1995-12-12       Impact factor: 3.688

6.  Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis.

Authors:  E Stickeler; F Kittrell; D Medina; S M Berget
Journal:  Oncogene       Date:  1999-06-17       Impact factor: 9.867

7.  SR splicing factors serve as adapter proteins for TAP-dependent mRNA export.

Authors:  Yingqun Huang; Renata Gattoni; James Stévenin; Joan A Steitz
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

8.  A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm.

Authors:  J F Cáceres; G R Screaton; A R Krainer
Journal:  Genes Dev       Date:  1998-01-01       Impact factor: 11.361

9.  Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20.

Authors:  Xiaolong He; P L Rachel Ee; John S Coon; William T Beck
Journal:  Clin Cancer Res       Date:  2004-07-15       Impact factor: 12.531

10.  A novel role for shuttling SR proteins in mRNA translation.

Authors:  Jeremy R Sanford; Nicola K Gray; Karsten Beckmann; Javier F Cáceres
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

View more
  30 in total

Review 1.  The RNAissance family: SR proteins as multifaceted regulators of gene expression.

Authors:  Jonathan M Howard; Jeremy R Sanford
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-08-22       Impact factor: 9.957

2.  Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence.

Authors:  Qi Long; Jianpeng Xu; Adeboye O Osunkoya; Soma Sannigrahi; Brent A Johnson; Wei Zhou; Theresa Gillespie; Jong Y Park; Robert K Nam; Linda Sugar; Aleksandra Stanimirovic; Arun K Seth; John A Petros; Carlos S Moreno
Journal:  Cancer Res       Date:  2014-04-08       Impact factor: 12.701

3.  Analysis of Pelagia noctiluca proteome Reveals a Red Fluorescent Protein, a Zinc Metalloproteinase and a Peroxiredoxin.

Authors:  Bárbara Frazão; Alexandre Campos; Hugo Osório; Benjamin Thomas; Sérgio Leandro; Alexandre Teixeira; Vitor Vasconcelos; Agostinho Antunes
Journal:  Protein J       Date:  2017-04       Impact factor: 2.371

4.  Post-transcriptional regulation of programmed cell death 4 (PDCD4) mRNA by the RNA-binding proteins human antigen R (HuR) and T-cell intracellular antigen 1 (TIA1).

Authors:  Callie P Wigington; Jeenah Jung; Emily A Rye; Sara L Belauret; Akahne M Philpot; Yue Feng; Philip J Santangelo; Anita H Corbett
Journal:  J Biol Chem       Date:  2014-12-17       Impact factor: 5.157

5.  Hsa_circ_0000437 promotes pathogenesis of gastric cancer and lymph node metastasis.

Authors:  Xianjuan Shen; Shan Kong; Shuo Ma; Lei Shen; Ming Zheng; Shiyi Qin; Jing Qi; Qiuhong Wang; Xiaopeng Cui; Shaoqing Ju
Journal:  Oncogene       Date:  2022-09-15       Impact factor: 8.756

6.  Tethered Function Assays as Tools to Elucidate the Molecular Roles of RNA-Binding Proteins.

Authors:  Tomas J Bos; Julia K Nussbacher; Stefan Aigner; Gene W Yeo
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 7.  Can we observe changes in mRNA "state"? Overview of methods to study mRNA interactions with regulatory proteins relevant in cancer related processes.

Authors:  C Zurla; J Jung; P J Santangelo
Journal:  Analyst       Date:  2016-01-21       Impact factor: 4.616

8.  The translational landscape of the splicing factor SRSF1 and its role in mitosis.

Authors:  Magdalena M Maslon; Sara R Heras; Nicolas Bellora; Eduardo Eyras; Javier F Cáceres
Journal:  Elife       Date:  2014-05-06       Impact factor: 8.140

9.  Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair.

Authors:  Xiaolong He; Pei Zhang
Journal:  Mol Cancer       Date:  2015-08-19       Impact factor: 27.401

10.  A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells.

Authors:  Masahiko Ajiro; Rong Jia; Yanqin Yang; Jun Zhu; Zhi-Ming Zheng
Journal:  Nucleic Acids Res       Date:  2015-12-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.